(Press-News.org) (PARIS, FRANCE) - Clearing blood clots from arteries during treatment for an acute myocardial infarction was a relatively common practice until a recent, large-scale study showed that the technique, known as thrombectomy, might actually increase the risk of stroke. Now, new insights from the TOTAL trial, presented here at EuroPCR 2015, indicate that the risk of stroke with thrombectomy during angioplasty, compared to angioplasty alone is evident very early following the procedure.
Dr. Sanjit Jolly, the study's lead author and an interventional cardiologist and Associate Professor at McMaster University in Hamilton, Ontario, Canada, said: "Given that thrombectomy has become a part of clinical practice, we felt it was very important to understand the stroke findings in the TOTAL trial."
The TOTAL trial compared the use of thrombectomy versus PCI alone in more than 10,000 patients hospitalized for a severe heart attack (ST-Elevation MI). For the study as a whole, the rate of cardiovascular death, MI, shock, or severe heart failure within 180 days were no different between the two groups. For the safety end point, looking at stroke within 30 days, TOTAL investigators saw a significant increase in the rate of strokes in the clot removal group than in the angioplasty-only group. This unexpected finding prompted Jolly and colleagues to dig deeper into the timing, severity, subtype, and predictors of stroke in TOTAL.
They found that the risk of a composite of stroke or transient ischaemic attack (TIA) was significantly higher in thrombectomy-treated patients than the angioplasty-only patients at 30 days (0.8% vs. 0.4%, p=0.003). This difference was also seen in the analysis that excluded minor events (TIAs) and focused solely on stroke. Investigators also saw a trend towards an increased risk of stroke with thrombectomy between 90 and 180 days, but this increase lacks "a plausible explanation" and may be due to chance, the authors say. Of note, there were no differences in anticoagulant or antiplatelet therapy at 30 days or 180 days to help explain the different stroke rates. A detailed landmark analysis, shows the highest risk period was within 48 hours.
Stroke severity as measured by modified Rankin scale also tended to be greater in the clot-removal group, and both ischaemic as well as haemorrhagic strokes were statistically more common in the thrombectomy-treated patients. Numbers were small, however, leading Jolly and colleagues to believe that the excess in haemorrhagic stroke may have occurred by chance.
"Given the findings of TOTAL, future device trials to remove thrombus from the coronary artery need to carefully collect and examine stroke outcomes in addition to efficacy outcomes," Jolly said.
Commenting on the study, Prof. Jean Marco, PCR Honorary Chairman, pointed out that the numbers of patients experiencing a stroke at 30 days (33 patients vs. 16, out of a total of 10,063) were very low, so the findings "may really be a matter of chance." As for the accumulation of additional strokes in both groups between 30 days and 180 days (19 additional strokes in the thrombectomy arm vs. 9 in the angioplasty-only group, "This is difficult to understand and again is probably a matter of chance."
Dr. Marco added, "The risk of stroke is a reality when performing thrombectomy, particularly if the basic rules for the correct use of the procedure are not followed. All tips and tricks for efficiency and safety with this procedure must be clearly explained, disseminated and implemented if this procedure is to be performed."
INFORMATION:
The TOTAL trial was funded by the Canadian Institutes of Health Research, Canadian Network and Centre for Trials Internationally (CANNeCTIN), and Medtronic Inc. The primary TOTAL results were presented earlier this year at the American College of Cardiology 2015 Scientific Sessions and published simultaneously in the New England Journal of Medicine. Jolly has disclosed receiving consultant fees or honoraria from AstraZeneca, research grants from Medtronic, and being on a speaker's bureau for St Jude Medical.
Contact: Dr. Sanjit Jolly McMaster University in Hamilton, Ontario, Canada
Associated EuroPCR 2015 Session: Hot Line: Primary PCI and STEMI in Practice, 13:35-14:35 CEST, Wednesday May 20, Room 252A
Notes to Editors
For more information on the abstracts featured in this press release, please contact Isabelle Uzielli, email: iuzielli@europcr.com
Further information on press registration may be found at http://www.europcr.com/page/press/619-press.html
What is EuroPCR?
EuroPCR, the official annual meeting of the European Association for Percutaneous Cardiovascular Interventions (EAPCI), a registered branch of the European Society of Cardiology, is the world-leading course in interventional medicine. PCR has established a distinctive format for educational activities in the field of cardiovascular interventions. Beyond its flagship course in Paris that gathers more than 12,000 participants every year, PCR organises annual courses in Singapore, London, Dubai and Cape Town. For further information on EuroPCR, AsiaPCR/SingLIVE, PCR London Valves, GulfPCR-GIM, AfricaPCR & PCR, please contact: Anne-Sophie Lartigau at aslartigau@europa-organisation.com.
For more information, please visit http://www.europcr.com
This beautiful planetary nebula is named after a dreadful creature from Greek mythology -- the Gorgon Medusa. It is also known as Sharpless 2-274 and is located in the constellation of [Gemini] (The Twins). The Medusa Nebula spans approximately four light-years and lies at a distance of about 1500 light-years. Despite its size it is extremely dim and hard to observe.
Medusa was a hideous creature with snakes in place of hair. These snakes are represented by the serpentine filaments of glowing gas in this nebula. The red glow from hydrogen and the fainter green emission ...
Noise from pile driving during offshore wind turbine construction could be damaging the hearing of harbour seals around the UK, according to ecologists who attached GPS data loggers to 24 harbor seals while offshore wind turbines were being installed in 2012. Data on the seals' locations and their diving behaviour was combined with information from the wind farm developers on when pile driving was taking place. Models revealed that half of the tagged seals were exposed to noise levels that exceeded hearing damage thresholds.
There are currently 1,184 offshore wind turbines ...
The harlequin ladybird, officially known as Harmonia axyridis, was widely introduced across continental Europe as a way to limit the population of small sap-sucking insects called aphids. While it was never intentionally introduced into Britain, H. axyridis was discovered there in 2003, and people across the region have been tracking its spread since 2005.
A new review in The Royal Entomological Society's journal Ecological Entomology notes that tens of thousands of people have provided records of H. axyridis and other species of ladybirds, creating an invaluable dataset ...
Gun violence restraining orders (GVROs) are a promising strategy for reducing firearm homicide and suicide in the United States, and should be considered by states seeking to address gun violence, researchers from the Johns Hopkins Center for Gun Policy and Research at the Johns Hopkins Bloomberg School of Public Health and the University of California, Davis, argue in a new report.
The article is being published online in Behavioral Sciences and the Law on May 20.
GVROs allow family members and intimate partners who believe a relative's dangerous behavior may lead ...
A new large study finds that women who are diagnosed with breast cancer and have a family history of the disease face no worse of a prognosis after treatment than other women with breast cancer. The study, which was published recently in the BJS (British Journal of Surgery), offers a positive message for women who may worry about their future in light of a family history of breast cancer.
About one- quarter of breast cancer cases in developed countries are thought to be related to hereditary factors. It can be scary for a woman to know that she has a family history of ...
This news release is available in French. A drug that could halt the progression of multiple sclerosis may soon be developed thanks to a discovery by a team at the CHUM Research Centre and the University of Montreal. The researchers have identified a molecule called MCAM, and they have shown that blocking this molecule could delay the onset of the disease and significantly slow its progression. These encouraging results from in vitro tests in humans and in vivo tests in mice were published today in the Annals of Neurology. "We believe we have identified the first therapy ...
Women with advanced ovarian cancer have fewer side effects and tend to have a better quality of life if given chemotherapy before surgery, according to a Cancer Research UK study published today (Wednesday) in The Lancet.
The CHORUS trial, conducted at the Medical Research Council Clinical Trials Unit at University College London, challenged the international standard for treating advanced ovarian cancer.
550 women with the disease took part in the trial, with 276 given the standard treatment of surgery followed by six cycles of chemotherapy, and 274 had surgery after ...
Researchers at the University of Birmingham have highlighted significant similarities between the behavioural effects of oxytocin and alcohol.
The research, published today in Neuroscience and Biobehavioral Reviews, draws on existing studies into the two compounds and details the similarities between the effects of alcohol and the 'love hormone', oxytocin, on our actions. The team warn that the oft-used nickname hides the darker side of oxytocin, and claim that it bears more semblances with the effects of alcohol than previously thought.
Oxytocin is a neuropeptide ...
Cold-blooded and other animals that are unable to regulate their internal temperature may have a hard time tolerating global warming, according to an analysis by biologists from the University of California, Berkeley, and San Francisco State University.
A meta-analysis of studies that measured the ability of animals to deal with extremes of heat and cold found that, on average, most ectotherms are not very flexible. Terrestrial ectotherms, such as lizards and insects, are even less adaptable than fish and crustaceans, they found.
As Earth warms, these animals will be ...
The proportion of people dying in hospices in England has nearly doubled since 1993, but the gap in hospice deaths between people living in the least and most deprived areas appears to be growing, find a new study by the Cicely Saunders Institute at King's College London.
The study, funded by the National Institute for Health Research HS&DR Programme (09/2000/58) through the NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC) and published in the journal Palliative Medicine, examined all hospice deaths in England over a 20-year period, including ...
